Depression in RA Patients May Be Higher Than Previously Reported
People with severe rheumatoid arthritis (RA) can be depressed about their health situation and anxious about what lies ahead. A new study looked at just how many people with RA were depressed.
When Nail Polish Doesn't Work
A regular manicure and pedicure probably won't be enough to relieve the pain and yellowing nails found in people with nail psoriasis. Regular psoriasis treatments may be the way to go.
To Switch or Not To Switch AS Drugs
No two patients with ankylosing spondylitis are exactly the same. As such, a drug treatment that works for one patient may not work for the other. When one drug isn't working out, patients may turn to another drug.
Dimming the Flame of Pain: Arthritis and All That
Your joints may feel tight. Your hips might hurt so bad that you can barely walk. Your back may feel so weak that you cannot even sit up straight. If you are experiencing these symptoms, you might have arthritis.
No Doubt About Arthritis Drug's Benefit
A few years ago, the FDA warned that certain drugs may raise the risk of cancer in children with juvenile arthritis. While it still seems these children are more prone to cancer, the drugs might not be to blame.
A Pain in the Back
Arthritis comes in many forms. One of these may have a funny sounding name, but the pain it brings is no laughing matter. It is called ankylosing spondylitis , and it is a pain in the back.
Psoriasis: Don't Hide From Help
As a child, Alisha B. had a few patches of what looked like a rash on her knees and elbows. She and her parents didn't think anything of it. Then things changed, and her skin has ever been the same since.
The RA Heart Left Unprotected
The inflammation of rheumatoid arthritis can affect more than the joints; it also poses a threat to the heart. When it comes to protecting the heart health of rheumatoid arthritis patients, certain drugs are falling short.
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.